Stabilised pharmaceutical composition of quinupristine and dalfopristine with methanesulphonic acid or hydrochloric acid

摘要

The stabilized pharmaceutical composition contains a quinupristine and dalfopristine combination and at least stoichiometric amounts of methanesulphonic acid or hydrochloric acid. The pH of the composition is within the range of 3.5 to 5.0. The concentration of the quinupristine/dalfopristine active principle is between 5 to 250 mg/ml